Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:2511:307-319.
doi: 10.1007/978-1-0716-2395-4_23.

Evaluation Protocol for SARS-CoV-2 Serological Assays

Maemu P Gededzha  1   2 , Sarika Jugwanth  3   4 , Nakampe Mampeule  3   4 , Nontobeko Zwane  3   4 , Anura David  5 , Lesley Scott  4   5 , Wendy Stevens  4   5 , Elizabeth S Mayne  3   4   6
Affiliations

Evaluation Protocol for SARS-CoV-2 Serological Assays

Maemu P Gededzha et al. Methods Mol Biol. 2022.

Abstract

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has been identified as the causative agent of COVID-19. Accurate detection of SARS-CoV-2 infection is not only important for management of infected individuals but also to break the chain of transmission. Although the polymerase chain reaction (PCR) is the gold standard for diagnosis of acute SARS-CoV-2 infection, there are a number of limitations of these assays, which include the inability to detect past infection and decline in sensitivity 14 days post-symptom onset. There are several serology tests developed for the detection of SARS-CoV-2 antibodies including high-throughput serology platforms and lateral flow immunoassays. These tests should be evaluated for their performance to meet local regulations acceptance criteria. To optimize the diagnostic algorithm for SARS-CoV-2, this protocol describes the evaluation of serological antibody testing using various automated serology platforms and lateral flow immunoassays. This protocol was evaluated in both serum and plasma samples. The sample preparation, procedure, and data analysis are described. The protocol can be adapted for any serological testing.

Keywords: Automated serology Platform; Lateral flow immunoassay; Precision; SARS-CoV-2 serology test.

PubMed Disclaimer

References

    1. Bobrovitz N, Arora RK, Cao C et al (2021) Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and metaanalysis. PLoS One 16(6):e0252617. https://doi.org/10.1371/journal.pone.0252617 - DOI - PubMed - PMC
    1. Müller SA, Wood RR, Hanefeld J et al (2021) Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence. Health Policy Plan:czab133. https://doi.org/10.1093/heapol/czab133
    1. Riollano-Cruz M, Akkoyun E, Briceno-Brito E et al (2021) Multisystem inflammatory syndrome in children related to COVID-19: a New York City experience. J Med Virol 93(1):424–433 - DOI
    1. Whittaker E, Bamford A, Kenny J et al (2020) Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 324(3):259–269 - DOI
    1. Mayne ES, Scott HL, Semete B et al (2020) The role of serological testing in the SARS-CoV-2 outbreak. S Afr Med J 110(9):842–845 - DOI

Publication types

Substances

LinkOut - more resources